You are here: Home » Companies » Start-ups » Start-up Corner
Business Standard

Cancer: Sayre Therapeutics aims for a spot among top 5 players in oncology

Apart from oncology, immunology is another key therapeutic area for Sayre

Sohini Das  |  Ahmedabad 

Bengaluru-based venture capital-promoted Sayre Therapeutics, which is working in the area of cancer diagnosis and treatment in India by bringing in international drugs, medical devices and diagnostics, is aiming for a spot among the top five players in oncology in the next five years.  The oncology drugs business in India is estimated to be around $500 million, and is growing at a compounded annual growth rate (CAGR) of 10-11 per cent. The diagnostics market is estimated to be seven-eight per cent of the drugs business.  Sayre Therapeutics Pvt Ltd was incorporated ...

TO READ THE FULL STORY, SUBSCRIBE NOW AT JUST Rs 149 A MONTH

Key stories on business-standard.com are available to premium subscribers only.

LOGIN

EMAIL / USER NAME
PASSWORD
REMEMBER ME Forgot password?

Not a member yet ? Resister Now

Connect using any below

  • Don't lose the opportunity of saving $26.77 per month
  • Don't lose the opportunity of saving $26.77 per month
Total Amount
Rs. 0.00
To proceed, kindly select a subscription package

WHAT YOU GET

On Business Standard Digital

  • Access your subscription from anywhere. Be it your computer, tablet or smartphone using a browser or the App, Your Choice.
  • Access to exclusive content, features, opinions and comment, hand-picked by our editors, just for you.
  • Pick your 5 favourite companies. Get all the news upates at the end of each day through E-Mail.
  • Pick the industry that you want to track. And get a daily news letter specific to that industry. Cut out the clutter.
  • And stay on top of your investments. Track stock prices in your portfolio
  • Access 18 years of archival data

On Digital

  • Seamless access to WSJ.com with your Business Standard digital account.
  • Experience the best of the Journal's reporting, video and interactive features.
  • Read about the people and events shaping business, finance, technology, politics, technology and culture.
  • Stay informed with newsletters - an easy way to get WSJ content straight to your inbox - making life easier on your busiest days.
  • More business executives read the Journal globally than any other publication.
*Note :
Our Partners are proud to be associated with this initiative and will contribute Rs 100 x 6 months thereafter, standard rate of Rs 149 will be charged.
Offer valid for Indian residents only
Requires you to share personal information like PAN, Date of Birth, and Income.
*Annual saving on WSJ subscription price of US$ 347.88 (12 months @ US$ 28.99 per month)
* 1US$ = 67.50 INR.
*Please note that this offer is not valid if you are/were a registered/existing user on WSJ Digital
First Published: Sun, September 03 2017. 22:38 IST
RECOMMENDED FOR YOU